UNSPSC 51421501: Fluticasone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H27F3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CUT2W21N7U, chemically known as s-(fluoromethyl) 6alpha,9-difluoro-11beta,17-dihydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta-carbothioate, 17-propionate but generally known as fluticasone, which bears US NIH Compound Identifier 54580. European Medicines Agency schedules Fluticasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07760MIG.

UNSPSC 51421501 Fluticasone is a Commodity code that represents a specific pharmaceutical product, but the recent state and local procurement activity posted under this code does not align with its nominal scope. Seminole County, Florida issued IFB60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually—neither of which is Fluticasone. The mismatch suggests that either the coding has been applied incorrectly to this opportunity or the source data reflects a data-entry error in the state procurement system. The stated scope of work under this code shows no relevant recent activity.

Without additional opportunities coded to UNSPSC 51421501 in the source block, no geographic pattern, repeat issuing bodies, or representative procurement pipeline can be characterized. A business development professional evaluating this code should verify the accurate UNSPSC classification for Fluticasone products in their target jurisdictions' procurement systems before pursuing opportunities, as the single recent posting under this code does not reflect the pharmaceutical product the code nominally describes.